Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any isolated congenital breast hypoplasia/aplasia in which the cause of the disease is a mutation in the PTPRF gene.
Features include common findings: Small earlobe, Highly arched eyebrow, Anteverted nares, and Absent nipple and others.
Age of onset: at birth.
PTPRF function has not been fully characterized.
Breasts and/or nipples, aplasia or hypoplasia of, 2 is associated with mutations in the PTPRF gene on chromosome 1.
Genetic testing for PTPRF is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for breasts and/or nipples, aplasia or hypoplasia of, 2 has been reported in the published literature.
Phenotype severity distribution: 12 common features.
No clinical trials have been registered for breasts and/or nipples, aplasia or hypoplasia of, 2.
308 publications have been identified in PubMed for breasts and/or nipples, aplasia or hypoplasia of, 2. Kisho has analyzed 129 by research type. Research spans Clinical Trial Publication (29%), Review / Meta-Analysis (22%), and Diagnostic / Biomarker (16%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 37 | 29% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 8:53 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Research summaries |
29 |
22% |
Testing and diagnosis research | 21 | 16% |
Disease patterns and progression | 20 | 16% |
Laboratory research | 12 | 9% |
Patient case studies | 9 | 7% |
Other research | 1 | 1% |
Widmayer P (2026). [PMID: 41967277](https://pubmed.ncbi.nlm.nih.gov/41967277/). *Eur J Radiol*. [Diagnostic / Biomarker]
Halperin Z (2026). [PMID: 40995837](https://pubmed.ncbi.nlm.nih.gov/40995837/). *Am J Med Genet A*. [Review / Meta-Analysis]
Tanas Y (2026). [PMID: 41776684](https://pubmed.ncbi.nlm.nih.gov/41776684/). *Syst Rev*. [Review / Meta-Analysis]
Tong X (2026). [PMID: 40555759](https://pubmed.ncbi.nlm.nih.gov/40555759/). *Nature biomedical engineering*. [Clinical Trial Publication]
Chang JM (2026). [PMID: 41528223](https://pubmed.ncbi.nlm.nih.gov/41528223/). *Radiology*. [Diagnostic / Biomarker]
Pedersen DC (2025). [PMID: 39798680](https://pubmed.ncbi.nlm.nih.gov/39798680/). *Annals of epidemiology*. [Basic Science / Preclinical]
Lo Gullo R (2025). [PMID: 40518301](https://pubmed.ncbi.nlm.nih.gov/40518301/). *Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine*. [Clinical Trial Publication]
Guido G (2025). [PMID: 40310009](https://pubmed.ncbi.nlm.nih.gov/40310009/). *Annals of plastic surgery*. [Clinical Trial Publication]
Qian X (2025). [PMID: 39633027](https://pubmed.ncbi.nlm.nih.gov/39633027/). *Nature biomedical engineering*. [Diagnostic / Biomarker]
Yang J (2025). [PMID: 40375587](https://pubmed.ncbi.nlm.nih.gov/40375587/). *Zhonghua zhong liu za zhi [Chinese journal of oncology]*. [Basic Science / Preclinical]